VNDA
Vanda Pharmaceuticals·NASDAQ
--
--(--)
--
--(--)
3.47 / 10
Netural
VNDA's fundamental profile is weak with a score of 3.5/10. Key risks include low year-over-year revenue growth (9.14%) and elevated days sales outstanding (82.96), both of which are in performance groups that historically underperform. Strengths such as a reasonable interest coverage ratio (15.48) and positive Profit-MV (0.46) are offset by these negatives, warranting defensive positioning.
Analysis Checks(6/10)
Revenue-MV
Value0.14
Score2/3
Weight17.36%
1M Return7.73%
Value0.14
Score2/3
Weight17.36%
1M Return7.73%
Days sales outstanding
Value82.96
Score1/3
Weight-2.44%
1M Return-1.57%
Value82.96
Score1/3
Weight-2.44%
1M Return-1.57%
Net income-Revenue
Value-0.17
Score2/3
Weight17.70%
1M Return8.45%
Value-0.17
Score2/3
Weight17.70%
1M Return8.45%
Interest coverage ratio (EBIT / Interest expense) (%)
Value15.48
Score2/3
Weight-1.77%
1M Return-1.11%
Value15.48
Score2/3
Weight-1.77%
1M Return-1.11%
Asset-MV
Value-0.50
Score0/3
Weight12.63%
1M Return5.75%
Value-0.50
Score0/3
Weight12.63%
1M Return5.75%
Total operating revenue (YoY growth rate %)
Value9.14
Score1/3
Weight-1.29%
1M Return-0.79%
Value9.14
Score1/3
Weight-1.29%
1M Return-0.79%
Profit-MV
Value0.46
Score2/3
Weight17.69%
1M Return8.45%
Value0.46
Score2/3
Weight17.69%
1M Return8.45%
PB-ROE
Value-0.56
Score3/3
Weight23.98%
1M Return12.83%
Value-0.56
Score3/3
Weight23.98%
1M Return12.83%
Operating revenue (YoY growth rate %)
Value9.14
Score1/3
Weight-1.25%
1M Return-0.76%
Value9.14
Score1/3
Weight-1.25%
1M Return-0.76%
Cash-MV
Value-0.07
Score2/3
Weight17.39%
1M Return8.41%
Value-0.07
Score2/3
Weight17.39%
1M Return8.41%
Revenue-MV
Value0.14
Score2/3
Weight17.36%
1M Return7.73%
Value0.14
Score2/3
Weight17.36%
1M Return7.73%
Total operating revenue (YoY growth rate %)
Value9.14
Score1/3
Weight-1.29%
1M Return-0.79%
Value9.14
Score1/3
Weight-1.29%
1M Return-0.79%
Days sales outstanding
Value82.96
Score1/3
Weight-2.44%
1M Return-1.57%
Value82.96
Score1/3
Weight-2.44%
1M Return-1.57%
Profit-MV
Value0.46
Score2/3
Weight17.69%
1M Return8.45%
Value0.46
Score2/3
Weight17.69%
1M Return8.45%
Net income-Revenue
Value-0.17
Score2/3
Weight17.70%
1M Return8.45%
Value-0.17
Score2/3
Weight17.70%
1M Return8.45%
PB-ROE
Value-0.56
Score3/3
Weight23.98%
1M Return12.83%
Value-0.56
Score3/3
Weight23.98%
1M Return12.83%
Interest coverage ratio (EBIT / Interest expense) (%)
Value15.48
Score2/3
Weight-1.77%
1M Return-1.11%
Value15.48
Score2/3
Weight-1.77%
1M Return-1.11%
Operating revenue (YoY growth rate %)
Value9.14
Score1/3
Weight-1.25%
1M Return-0.76%
Value9.14
Score1/3
Weight-1.25%
1M Return-0.76%
Asset-MV
Value-0.50
Score0/3
Weight12.63%
1M Return5.75%
Value-0.50
Score0/3
Weight12.63%
1M Return5.75%
Cash-MV
Value-0.07
Score2/3
Weight17.39%
1M Return8.41%
Value-0.07
Score2/3
Weight17.39%
1M Return8.41%
Is VNDA undervalued or overvalued?
- VNDA scores 3.47/10 on fundamentals and holds a Fair valuation at present. Backed by its -15.79% ROE, -39.70% net margin, -5.31 P/E ratio, 0.96 P/B ratio, and -396.55% earnings growth, these metrics solidify its Netural investment rating.
